{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/psychosis-schizophrenia/management/women-of-childbearing-age/","result":{"pageContext":{"chapter":{"id":"c20919b9-2e4c-5c56-b3cd-7fb432199a8b","slug":"women-of-childbearing-age","fullItemName":"Scenario: Women of childbearing age","depth":2,"htmlHeader":"<!-- begin field a49d09eb-3349-40b3-807e-0aba8ecb76b3 --><h2>Scenario: Women of childbearing age with psychosis or schizophrenia</h2><!-- end field a49d09eb-3349-40b3-807e-0aba8ecb76b3 -->","summary":"Covers the management of women with a psychotic disorder who are planning a pregnancy, who present with an unplanned pregnancy, or who are planning to breastfeed.","htmlStringContent":"<!-- begin item 4bb91e2f-3e59-4264-887f-bec59d504a39 --><!-- begin field a86a9c71-c883-4a69-b299-acbd00868168 --><p>From age 18 years onwards.</p><!-- end field a86a9c71-c883-4a69-b299-acbd00868168 --><!-- end item 4bb91e2f-3e59-4264-887f-bec59d504a39 -->","topic":{"id":"9b90da89-2ffd-5b6a-9fc6-ea342404d5d8","topicId":"fd02ebc3-0f02-42b5-8737-e0608ca4330d","topicName":"Psychosis and schizophrenia","slug":"psychosis-schizophrenia","lastRevised":"Last revised in November 2020","chapters":[{"id":"d60310a0-752b-5399-8488-a567bf6a3925","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"10869ad6-510d-54db-bc6a-ce3618a1c478","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1025e31f-c89d-5344-b4ae-d5e8950a5c0e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"594160f5-1a9b-56f0-952c-5c400ea28785","slug":"changes","fullItemName":"Changes"},{"id":"e20c0ce8-30f6-5e09-81d1-3e6005f85efe","slug":"update","fullItemName":"Update"}]},{"id":"4c4f0990-85fa-5fc4-9a58-9f02a868a971","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"02637a5f-4552-5e73-9245-cf480497e9a5","slug":"goals","fullItemName":"Goals"},{"id":"8c88de52-9655-52d8-b302-67641ae05beb","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c6754da2-fd29-5d45-8097-40b8ec0589cd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"31a210b8-403b-5530-b1ea-0b44a2595f07","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c5630117-b04c-558a-b516-41c3eab9adbd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e9e078fd-a616-51bf-944f-2efbb2a01feb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"99d1cff5-adca-5573-9fa8-58c2e9f937e0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"23ac3781-557a-57b8-95b5-83db37a53fda","slug":"definition","fullItemName":"Definition"},{"id":"3e7238cc-23d8-56f6-a8af-255ed6a876d7","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"9576e7c9-3a1e-57d3-bb86-a4e5e10462e1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b79b29b0-d7ad-5bad-87fd-e5a48ced5427","slug":"course-prognosis","fullItemName":"Course and prognosis"},{"id":"598444d7-6337-5133-a088-176b1f83ab01","slug":"complications","fullItemName":"Complications"}]},{"id":"a913b80f-eec4-5c47-9d9c-0b20f4648b73","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e7897095-2be8-5df7-a7e3-c1060d4a453a","slug":"identifying-someone-at-risk-of-a-psychotic-disorder-or-experiencing-their-first-episode-of-psychosis","fullItemName":"Identifying someone at risk of a psychotic disorder or experiencing their first episode of psychosis"},{"id":"a8f36210-9cb6-590b-8e3d-7ddbc6d31e88","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f86ff69c-c33e-5b8c-affa-04759f25bf5a","fullItemName":"Management","slug":"management","subChapters":[{"id":"34c0807e-9463-536b-9ff4-c3537046a6ba","slug":"primary-care-management","fullItemName":"Scenario: Primary care management"},{"id":"468f8b6f-bc79-5ecd-b1c2-d7ff27721abe","slug":"managing-relapse","fullItemName":"Scenario: Managing relapse"},{"id":"30f16f24-0127-53b7-bd08-c679a189090b","slug":"the-routine-schizophrenia-or-psychosis-review","fullItemName":"Scenario: The routine schizophrenia or psychosis review"},{"id":"c20919b9-2e4c-5c56-b3cd-7fb432199a8b","slug":"women-of-childbearing-age","fullItemName":"Scenario: Women of childbearing age"}]},{"id":"a9fe56bb-7ae3-5523-b0e2-5b7da5aa8439","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f78f8497-f98b-5445-82fe-23a4ced38576","slug":"available-antipsychotics","fullItemName":"Available antipsychotics"},{"id":"05e42d64-ee5a-5c2b-8817-5fc77abb19ec","slug":"adverse-effects","fullItemName":"Adverse effects"},{"id":"25b3e7d5-bc3d-5749-9304-a717c1f4e386","slug":"interactions","fullItemName":"Interactions"},{"id":"ed339043-f5e2-5209-9ba0-cb06890e1050","slug":"monitoring","fullItemName":"Monitoring"}]},{"id":"7ae82132-000d-507c-b73d-542c43656041","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1bf0a6af-76cf-5f6b-b7fb-4c746ff0f413","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"49b46ed4-7209-5c01-b07f-54117f9ad3c0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a4647644-8726-5bfc-b471-6e157c3f10a3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a31ae673-4520-58d5-95ee-db2395fb5238","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3beebe4c-a826-5b46-a8cd-a97fe8ec3b8b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"aaaadecf-036b-531f-a8bf-75fccd84219f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"49078833-deae-54f3-ad89-562370e4d181","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f86ff69c-c33e-5b8c-affa-04759f25bf5a","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"fcaa011c-b103-5b53-ada4-909c1dcbed5f","slug":"pregnancy-planned-unplanned","fullItemName":"Pregnancy (planned and unplanned)","depth":3,"htmlHeader":"<!-- begin field b4ed6bf3-b5b6-41b3-9ede-5f1909cd6564 --><h3>How should I manage a woman with psychosis or schizophrenia who is planning a pregnancy or presents with unplanned pregnancy?</h3><!-- end field b4ed6bf3-b5b6-41b3-9ede-5f1909cd6564 -->","summary":null,"htmlStringContent":"<!-- begin item e607b7c1-12fe-4915-9e1f-1091fc0db1b5 --><!-- begin field 605bca26-5c35-45c2-a0d4-4f713ee15dc9 --><ul><li><strong>Refer women who are pregnant or planning a pregnancy to a specialist perinatal mental health service if available, or to the community mental health service for an assessment and discussion of drug treatment.</strong></li><li><strong>Do not alter or stop drug treatment (and advise the woman not to alter her own medication) without seeking specialist advice.</strong><ul><li>Explain to the woman that following discussion with a specialist of the risks to the mother of under-treatment (relapse), the potential benefits of a particular treatment, and the (largely hypothetical) risks to the fetus that may be associated with any drug treatment, she may be offered the following options:<ul><li>Remaining on current drug treatment throughout conception, pregnancy, and birth  — commonly advised when a woman's condition is well-controlled.</li><li>Switching to another drug treatment.</li><li>Stopping or reducing the dose of her medication.</li></ul></li><li>Patient information leaflets on use of aripiprazole, clozapine, olanzapine, and quetiapine in pregnancy are available from the <a data-hyperlink-id=\"b181e20e-aeb5-4e62-b9db-ab4c00a25512\" href=\"https://www.medicinesinpregnancy.org/\">UK Teratology Information Service</a>.</li><li>Discuss the likelihood that sleep and routine will be disturbed after the baby is born. Participate in multi-agency plans for practical support after the baby is born (from the woman's family, health visitor, organizations such as Sure Start, and social care) so that the woman gets enough rest and sleep.</li></ul></li><li><strong>For women who are planning a pregnancy, give general pre-conception advice (such as cessation of smoking and alcohol consumption) and prescribe folic acid. Note that a high dose (5 mg/day) is indicated in women taking certain medications and who are obese.</strong><ul><li>For more detailed information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pre-conception-advice-management/\">Pre-conception - advice and management</a>.</li></ul></li><li><strong>Be aware that women in the postnatal period are at increased risk of </strong><a class=\"topic-reference internal-reference\" href=\"/topics/psychosis-schizophrenia/management/managing-relapse/#management\">relapse</a><strong> of psychotic symptoms.</strong></li></ul><!-- end field 605bca26-5c35-45c2-a0d4-4f713ee15dc9 --><!-- end item e607b7c1-12fe-4915-9e1f-1091fc0db1b5 -->","subChapters":[{"id":"727e9120-c7e9-5eac-9829-30efa0b36e58","slug":"basis-for-recommendation-dc4","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 371e035c-a93d-4ba3-b05e-4f89b8502caa --><h4>Basis for recommendation</h4><!-- end field 371e035c-a93d-4ba3-b05e-4f89b8502caa -->","summary":null,"htmlStringContent":"<!-- begin item dc4f1079-466c-4536-8ee3-75127ce4a796 --><!-- begin field 8744f420-b486-45df-934f-019e8d58f39b --><p>These recommendations are largely based on expert opinion in the British Association for Psychopharmacology guideline <em>Use of psychotropic medication preconception, in pregnancy and postpartum</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psychosis-schizophrenia/references/\">McAllister-Williams et al, 2017</a>] and the National Institute of Health and Care Excellence (NICE) guideline <em>Antenatal and postnatal mental health: clinical management and service guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psychosis-schizophrenia/references/\">NICE, 2018</a>].</p><h5>Referral</h5><ul><li>The recommendation to refer to community mental health services where specialist perinatal mental health services are unavailable is pragmatic, based on what CKS considers to be good clinical practice. Specialist input is required, but the local availability of specific perinatal psychiatric services is variable.</li></ul><h5>Sleep routine, pre-conception advice</h5><ul><li>The advice that women who are pregnant or considering pregnancy should be offered information about likely effects on their sleep routine and general pre-conception advice is pragmatic, based on what CKS considers to be good clinical practice.</li></ul><!-- end field 8744f420-b486-45df-934f-019e8d58f39b --><!-- end item dc4f1079-466c-4536-8ee3-75127ce4a796 -->","subChapters":[]}]},{"id":"0c832c3b-def4-5606-b55e-57b05e8978bd","slug":"breastfeeding","fullItemName":"Breastfeeding","depth":3,"htmlHeader":"<!-- begin field 185bfe96-9c01-4941-982d-626e91e7f24c --><h3>What issues should I consider if a woman is breastfeeding?</h3><!-- end field 185bfe96-9c01-4941-982d-626e91e7f24c -->","summary":null,"htmlStringContent":"<!-- begin item b976fcf9-9b64-4fbd-9c23-34015384e2d6 --><!-- begin field a6a792da-11fc-4687-8461-fed36090de73 --><ul><li><strong>Support a woman with a psychotic disorder in the choice of feeding method that best suits her and her family. </strong>Breastfeeding may be appropriate unless the woman is taking clozapine. Ensure support for women who choose not to breastfeed.</li><li><strong>Infants exposed via breastmilk to antipsychotics should, as a precaution, be monitored for adverse effects</strong>, particularly if at high risk (e.g. preterm or low birth weight infants). These may include drowsiness, irritability, motor abnormalities and poor feeding.</li><li><strong>If more advice on breastfeeding and medication is required, </strong>liaise with specialist mental health services or seek specialist advice from the UK Drugs in Lactation Advisory Service: telephone 0121 311 1974, or 0121 378 2211.</li></ul><!-- end field a6a792da-11fc-4687-8461-fed36090de73 --><!-- end item b976fcf9-9b64-4fbd-9c23-34015384e2d6 -->","subChapters":[{"id":"b3c1e8ba-8c8d-5705-b42e-cdbf42085a18","slug":"basis-for-recommendation-04f","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e8a6aed1-689f-4ceb-bdcf-8ef87f94931d --><h4>Basis for recommendation</h4><!-- end field e8a6aed1-689f-4ceb-bdcf-8ef87f94931d -->","summary":null,"htmlStringContent":"<!-- begin item 04f85039-1794-4292-9e7d-a39e94886ed2 --><!-- begin field c3bc6e06-5dfc-4c15-8154-3a00f9e53be5 --><p>These recommendations are largely based on expert opinion in the British Association for Psychopharmacology guideline <em>Use of psychotropic medication preconception, in pregnancy and postpartum</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psychosis-schizophrenia/references/\">McAllister-Williams et al, 2017</a>] and the National Institute of Health and Care Excellence (NICE) guideline <em>Antenatal and postnatal mental health: clinical management and service guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psychosis-schizophrenia/references/\">NICE, 2018</a>].</p><h5>Sources of Information</h5><ul><li>The advice to contact the UK Drugs in Lactation Advisory Service or to liaise with specialist mental health services when a woman taking medication for bipolar disorder wishes to breastfeed is pragmatic, based on what CKS considers to be good clinical practice. </li></ul><!-- end field c3bc6e06-5dfc-4c15-8154-3a00f9e53be5 --><!-- end item 04f85039-1794-4292-9e7d-a39e94886ed2 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}